PET imaging of breast cancer in clinical practice
ثبت نشده
چکیده
Imaging options There are several imaging options capable of identifying and defining breast cancer. These include X-ray mammography, ultrasound, computer tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET). Newer modalities such as positron emission mammography (PEM) or near infrared spectroscopy (NIRS), recently or soon to be available in clinical practice, may replace MRI or PET for the detection of the primary lesion. A.E. Larhs Director of Nuclear Medicine and Clinical Positron Emission Tomography, Tacoma Radiological Associates Medical Imaging, Tacoma, WA, U.S.A.
منابع مشابه
Molecular imaging approaches in the diagnosis of breast cancer: A systematic review and meta-analysis
Introduction:The accuracy of positron emission tomography with computed tomography (PET/CT), positron emission mammography (PEM), and breast specific-gamma imaging (BSGI) in diagnosing breast cancer has never been systematically assessed, the present systematic review was aimed to address this issue. Methods:PubMed, Scopus and EMBASE were searched for st...
متن کاملEvaluation of the Possible Utilization of 68Ga-DOTATOC in Diagnosis of Adenocarcinoma Breast Cancer
Objective(s): Studies have indicated advantageous properties of [DOTA-DPhe1 , Tyr3 ] octreotide (DOTATOC) in tumor models and labeling with gallium. Breast cancer is the second leading cause of cancer mortality in women, and most of these cancers are often an adenocarcinoma. Due to the importance of target to non-target ratios in the efficacy of diagnosis, the pharmacokinetic of 68Ga-DOTATOC in...
متن کاملBreast cancer imaging: a new role of Tc-99m sestamibi prone scintimammography for diagnosisof breast cancer
Mammography remians the procedure of choice in screening asymptomatic women for breast cancer. However, in patients with symptoms, other types of imaging play an important role in the detection of malignancies. The high cost and lack of availability of PET and MRI largely precludes the use in this patient population. TI-201 is nbt the imaging agent of choice because of its wash-out and redistri...
متن کاملDiagnostic Accuracy of Positron Emission Mammography with 18F-fluorodeoxyglucose in Breast Cancer Tumor of Less than 20 mm in Size
Objective(s): To investigate the diagnostic accuracy of positron emission mammography (PEM) and positron emission tomography/computed tomography (PET/CT) for small breast tumors of less than 20 mm in size.Methods: The study was conducted on a total of 100 subjects (i.e., 50 patients with pathologically proven breast cancer and 50 normal cases of medical screening). The total number of tumors wa...
متن کاملPredictive ability of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for pathological complete response and prognosis after neoadjuvant chemotherapy in triple-negative breast cancer patients
Objective The mortality of patients with locally advanced triple-negative breast cancer (TNBC) is high, and pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is associated with improved prognosis. This retrospective study was designed and powered to investigate the ability of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) to predict pat...
متن کامل